Cannabis Law Report
JUNE 28, 2021
Drug Enforcement Agency (“DEA”). CBP did disclose a “Seized Asset Management and Enforcement Procedures Handbook,” dated January 2002, that it said explains the CBP policies related to seizing and destroying controlled substances like ayahuasca. Drug Enforcement Administration (DEA). Customs Border Patrol (“CBP”) and U.S.
PrestoDoctor
JULY 16, 2019
The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. According to plaintiff José Belén, “the DEA was told to act with ‘great dispatch’ and with ‘all deliberate speed”. Americans for Safe Access (ASA).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PrestoDoctor
JULY 16, 2019
The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. According to plaintiff José Belén, “the DEA was told to act with ‘great dispatch’ and with ‘all deliberate speed”. Americans for Safe Access (ASA).
Cannabis Law Report
JULY 12, 2019
31) The United States DEA has stated that small amounts of other cannabinoids will also occur in all cannabis extracts, even those that purport to be CBD only – unless synthesized de novo, CBD isolate will always contain small amounts of THC when extracted from a plant. 2002 Jun;42(8):993-1007. 32: United States DEA.
Cannabis Law Report
JULY 9, 2021
Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D.,
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 2, 2002 , 116 Stat. 2, 2002 , 116 Stat. 2, 2002 , 116 Stat. 2, 2002 , 116 Stat.
Expert insights. Personalized for you.
97 
Let's personalize your content